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Abstract
The thyroid hormone receptor a  (TRa) is a transcription factor, which can 
activate or repress gene expression in response to thyroid hormone. In addition, some of 
its actions, including DNA binding and transcriptional activation, are thought to be 
regulated by phosphorylation. Results presented here, using Xenopus oocyte 
micro injection assays, demonstrate that a phosphorylated form of TRa is present in the 
oocyte nucleus, whereas unphosphorylated TRa remains cytoplasmic. Changes in the 
phosphorylation state of TRa occur rapidly in Xenopus oocytes and point to the 
possibility that phosphorylation occurs in the nucleus. Furthermore, increasing the 
overall phosphorylation state of the oocyte leads to enhanced nuclear retention of TRa, 
suggesting that phosphorylation may have an important role in regulating nuclear 
localization of TRa. However, serine 12, a well-characterized casein kinase II 
phosphorylation site, is not necessary for this enhanced nuclear retention, nor is this site 
necessary for nuclear import. Taken together, these data provide evidence that 
phosphorylation of one or more sites other than serine 1 2 , while not directly involved in 
nuclear import, play an important role in regulating nuclear retention of TRa. These 
findings provide a foundation for future studies on the role of phosphorylation in the 
regulation of TRa.
TR PHOSPHORYLATION & NUCLEAR IMPORT
Introduction
The thyroid hormone receptor (TR), like other members of the nuclear receptor 
superfamily, is a transcription factor that activates or inhibits the expression of target 
genes in response to ligand. These transcription factors play a vital role in the normal 
development and maintenance of homeostasis in many organisms. Mutant alleles of 
members of this family have also been linked to a variety of diseases including various 
forms of cancer and resistance to thyroid hormone. In recent years, phosphorylation of 
transcription factors such as TR has been shown to be an important regulatory factor in 
many systems. Along with tremendous advances in our understanding of TR 
phosphorylation, there has also been a great deal of confusion in the literature, as well as 
a host of new questions to be answered. This thesis will address the importance of 
phosphorylation in the nuclear localization of TR. The following introduction will 
review what is currently known about the thyroid hormone and how TR mediates its 
functions. What is known about the structure of TR, its subcellular trafficking, and how it 
acts on target genes will be addressed.
Thyroid hormone production and regulation
Two of the most important hormones in the body are triiodothyronine (T3 ) and 
tetraiodothyronine (T4 ), collectively known as the thyroid hormones. T3 is the 
physiologically active form; T4  is converted to T3 at the target tissue. A tight endocrine 
pathway regulates thyroid hormone release (Fig. 1). Regulation begins in the brain,
2
3specifically the hypothalamus. The hypothalamus releases thyrotropin releasing hormone 
(TRH) which travels through the blood of the hypothalamo-hypophysial portal system. 
This hormone then acts on the pituitary gland, specifically the adenohypophysis. The 
adenohypophysis secretes thyroid stimulating hormone (TSH) into the bloodstream, 
which travels through the blood and acts on the thyroid gland. The binding of TSH to its 
cell surface receptor on the thyroid gland begins a cellular cascade which ultimately leads 
to the production and release of the thyroid hormones (Wilson, 1998). The thyroid 
hormones then travel through the blood as a complex with specific binding proteins to 
their target organs or tissues. These specific binding proteins are thyroxine-binding 
globulin (TBG) and transthyretin (TTR) (Wilson, 1998). Once T3 reaches its target cell, 
it is believed to enter the cell by a carrier-mediated, energy-dependent process, though 
some hormone may diffuse passively through the plasma membrane due to its lipophilic 
constitution (Ichikawa et al., 2000; Wilson, 1998). It then enters the nucleus, possibly in 
association with cytoplasmic thyroid hormone-binding protein (CTBP). Once in the 
nucleus, T3 is released from CTBP and binds TR (Ichikawa et al., 2000; Nagasawa et al., 
1995).
There are multiple iso forms of TR, which may compete for the limited numbers 
of thyroid hormone response elements available (Leitman et al., 1996). Two genes code 
for TRa and TRp respectively. The TRa locus is located on chromosome 17 in humans. 
Alternative splicing creates two iso forms, TRal and TRa2. TRa2 is incapable of binding 
T3 and it is believed that it may act as a repressor of T3 -dependent gene transcription 
(Tsai and O'Malley, 1994; Wilson, 1998). The TRp locus is found on human 
chromosome 3.
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Figure 1. Secretory pathway of the thyroid hormones. Regulation begins 
in the hypothalamus with the release of TRH. TRH stimulates the 
adenohypophysis to secrete TSH. TSH then binds to cell surface receptors on 
the thyroid gland, which leads to the release of the thyroid hormones. The 
thyroid hormone then enters the cell and enters the nucleus, binds to TR and, 
in most cases, enhances transcription.
5Alternative splicing and separate promoters create the iso forms TR(31 and TRp2 
(Gauthier et al., 1999; www.thyroidmanager.org/Chapterl6/16d-text.htm). In the absence 
of ligand, TR is usually loosely bound to target gene sequences. However, upon 
hormone binding, a conformational change is induced in TR, which strengthens the 
receptor’s association with DNA. Furthermore, hormone binding promotes receptor 
dimerization (Tsai and O'Malley, 1994), which will be discussed in a later section.
Role o f thyroid hormone in the body
T3 has been shown to have an important role in reproduction, differentiation of 
certain cell types, development of various tissues, and maintenance of homeostasis in 
adults. These functions of T3 are mediated by the TRs (Lin et al., 1992; Wilson, 1998). 
Some specific functions of T3 include control of amphibian metamorphosis, and, in 
mammals, cardiac output, ventilation, mobilization o f food stores, and body temperature 
control via thermogenesis and sweating mechanisms (Eliceiri and Brown, 1994; Sachs et 
al., 2000; Wilson, 1998). Many of these studies concerning the effects of T3 involve the 
use of knockout mice, who lack either the TRa gene, the TRp gene, or both. For 
example Riisch et al. (1998) demonstrated that TRp deficient mice have abnormal 
hearing development. They further pointed out that these mice have problems with 
potassium conductance, which occurs at the inner ear hair cells. Studies of TRp deficient 
mice have also shown that this iso form is the main regulator for TSH release and, in its 
absence, extremely high levels of T3 and T4  can be found in the blood. TRa can stimulate 
TSH release, but at a much less efficient level than TRp (Forrest and Vennstrom, 2000; 
Gauthier et al., 1999).
6TRa deficient mice have also been produced. These mice die within five weeks 
due to growth arrest, and have major defects in bone and small intestine development 
(Fraichard et a l, 1997; Gauthier et a l, 1999). Further studies suggest that TRal may be 
involved in both control of heart rate and body temperature. TRa knockout-mice had an 
average heart rate 20% lower than the wild type and also showed a 0.5°C lower body 
temperature (Wikstrom et al., 1998). Mice lacking TRal and TRa2 also have a 
deficiency in T and B lymphocyte development. B lymphocytes were most profoundly 
affected, showing a considerable lack of B cell progenitor proliferation. However, what 
remains unclear is how TRa is controlling the B cell population, whether by direct 
interaction or by creating an environment that promotes B cell differentiation (Arpin et 
al., 2 0 0 0 ).
As stated earlier, T3 is very important for development and adult homeostasis. 
Deficiency or overproduction of T3 or T4 , or genetic defects in TR can lead to a disease 
state. In humans, both hyper- and hypothyroidism have been documented (Wilson,
1998). There are two main forms of hyperthyroidism. One form is caused by mutant 
TSH receptors that are activated in the absence of hormone and stimulate the thyroid 
gland to produce an excess of T3 . The second form is Graves’ disease which is caused by 
autoantibodies produced against an individual’s own TSH receptors. These 
autoantibodies activate the same pathway as a normal TSH receptor bound by hormone. 
Individuals with hyperthyroidism have dramatic weight loss due to a large increase in 
metabolic rate, excessive sweating due to increased heat production, weakness associated 
with muscle loss, and presence of goiter (an enlarged thyroid gland) (Wilson, 1998). A 
major cause of hypothyroidism is a deficiency of iodine, a component of both T3 and T4 .
7Hypothyroidism leads to cretinism which is diagnosed by especially short stature, 
obesity, malformed legs, and mental retardation (Wilson, 1998). Resistance to thyroid 
hormone is the major heritable disease associated with mutations in TRp. Mutations are 
primarily located in the T3 -binding domain and the adjacent hinge region. Inheritance of 
this disease is autosomal dominant but resistance is never complete. Individuals with this 
disease experience a wide range of symptoms including goiter, abnormally high T3 levels, 
and varying degrees of slowed development (www.thyroidmanager.org/Chapterl6/16d- 
text.htm).
Characteristics o f  TR and other members o f the nuclear receptor superfamily
TR is a member of the large steroid/thyroid superfamily of nuclear receptors, 
which includes the receptors for steroid hormones, vitamin D receptor, retinoic acid 
receptor (RAR), and the retinoid X receptor (RXR), as well as orphan receptors whose 
ligand and/or function are currently unknown. These receptors act as transcription 
factors which can either repress or enhance transcription of target genes (Weigel, 1996). 
TRs bind to DNA at specific sites called thyroid hormone response elements (TREs) as 
monomers, homodimers, and as heterodimers with RXR (Leitman et al., 1996; Tsai and 
O'Malley, 1994). These TREs can be inverted, direct, or even everted repeats, with each 
half site having a similar homology to the estrogen response element (Tsai and O'Malley, 
1994).
All members of this family share functional amino acid domains named A 
through F (Fig. 2). The A/B regions of the N-terminus are weakly conserved, are 
variable in length and contain an autonomous transcriptional activation function
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Figure 2. A. Domains of the nuclear receptor superfamily. The A/B
domains are weakly conserved. The C domain contains the DNA binding 
domain (DBD). The D domain contains the variable hinge region. The E 
domain contains the highly conserved ligand binding domain (LBD). The F 
domain is weakly conserved, is absent in some members such as the thyroid 
hormone receptor and has no known function. B. Domains of the thyroid 
hormone receptor. The A/B region contains the phosphorylation site at serine 
12. The D domain contains the NLS.
(Robyr et al., 2000). The C region includes the highly conserved DNA binding region, 
which is comprised of two Zn2+containing motifs called “zinc fingers” (Robyr et al., 
2000; Weigel, 1996). The D domain is a variable hinge region. Domain E is also highly 
conserved and contains the ligand binding domain, a second transactivation function, a 
dimerization domain, and a region involved in nuclear localization. This second 
transactivation function is an amphipathic a-helix that is highly conserved and is critical 
for transcriptional activation (Robyr et al., 2000). The final region F has no known 
function and is highly variable across the superfamily, including complete absence of the 
region in TR, the progesterone receptor (PR), RAR, and RXR (Robyr et al., 2000).
TR binding to DNA
TRs, like their counterparts in the superfamily, can bind DNA in multiple forms. 
First, as mentioned above, TR can bind to TREs as a monomer, homodimer, or 
heterodimer. These various protein-protein interactions regulate transcriptional activity 
(Weigel, 1996). For example, TR preferentially forms heterodimers with RXR. There 
are three RXR isoforms, a , p, and y. Thus, the regulatory outcome of binding o f TR to 
its target sequence will depend upon to which RXR variant it is bound (Weigel, 1996). 
Also, as stated earlier, there are multiple isoforms of TR which may compete for the 
limited numbers of TREs available. Furthermore, the distribution of these iso forms is 
different. TRa is found mainly in the brain, gut, and lung (Macchia et al., 2000). TRp 
shows a wider distribution and appears to be more important at the adult stage (Forrest 
and Vennstrom, 2000). Thus, several mechanisms exist which can alter the effect of T3.
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The effect not only depends on how TR binds to DNA, but also which iso form has bound 
the hormone.
Nuclear import
Since all proteins are synthesized in the cytoplasm, nuclear proteins must have a 
mechanism to enter the nucleus in order to perform their activity. As transcription factors, 
members of the steroid/thyroid superfamily fall into this category. Traffic from the 
cytoplasm to the nucleus and vice versa is regulated through the nuclear pore complex. 
The nuclear pore is a protein complex embedded in the nuclear membrane. It is 
composed of 50-100 subunits which form a three-dimensional structure that has an 
eightfold rotational symmetry. Both faces have rings that are connected via central 
spokes creating a central channel for proteins to pass through. The cytoplasmic face has 
eight filaments, which project away from the nucleus into the cytoplasm. The nuclear 
face of this structure has a basket-like structure, which points inward (Corbett and Silver, 
1997; Newmeyer, 1993).
Proteins entering, exiting, or even shuttling between the cytoplasm and the 
nucleus generally have a signal, which allows them to be properly targeted. Shuttling is 
the phenomenon where a protein seems to be localized to a specific subcellular 
compartment; however, in reality, individual proteins are being both imported and 
exported, with one of the rates substantially slower than the other leading to a more 
localized state. Both nuclear localization signals (NLS) and nuclear export signals (NES) 
have been identified. Two signals which have been well characterized are the simian 
virus 40 large T-antigen (also known as the classical NLS) and the nucleoplasmin 
bipartite NLS. The classical NLS is a stretch of basic amino acids, while the bipartite
11
NLS is made up of two basic amino acid stretches separated by a 10 residue spacer 
region.
For larger proteins, both import and export are usually energy-dependent 
processes, although export may not specifically require GTP hydrolysis. Passive diffusion 
does occur in some cases with proteins that are less than 40-60 kD, though many of these 
smaller proteins are actively imported since this pathway is more efficient (Corbett and 
Silver, 1997; Guichon-Mantel et al., 1996; Kaffman and O'Shea, 1999; Okamoto et al., 
1999). Results of a series of experiments by Bunn et al. (2001) strongly suggest that, in 
Xenopus oocytes, TR undergoes passive diffusion for its entry into the nucleus. The 
authors showed that TR import in Xenopus oocytes is temperature and energy- 
independent. Furthermore, they demonstrated that inhibitors of signal-mediated import, 
wheat germ agglutinin and Ran Q69L, do not inhibit the nuclear import of TR. 
Interestingly, TR can also enter the oocyte nucleus by a signal-mediated pathway. This 
latter pathway will be discussed in more detail later.
The mechanism for the import of many proteins with a classical NLS begins with 
the cargo protein binding directly to the importin a  subunit of the importin a- importin p 
heterodimer complex (Fig. 3). Following binding, this complex is targeted to the 
cytoplasmic filaments of the nuclear pore complex by the importin p subunit. At the 
nuclear pore, in the presence of Ran-GDP, the importin-cargo protein complex 
is translocated into the nucleus through the central channel of the nuclear pore complex. 
In a separate pathway, Ran-GDP also enters the nucleus and is converted to Ran-GTP by 
the Prp20p and RCC1 exchange factors. Within the nucleus Ran-GTP binds to the 
importin-cargo complex, which causes the dissociation of the importin complex from the
12
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Figure 3. Nuclear import of proteins with a classical NLS. The
cargo protein bearing a classical NLS binds the importin a/p complex 
and is translocated to the nucleus. Ran GTP binds to this complex 
causing the release of the cargo protein. The Ran/importin complex is 
exported to the cytoplasm for another round of import.
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cargo protein. After dissociation, the importin subunits are recycled back to the 
cytoplasm in a process that requires GTP hydrolysis by Ran. The cargo protein is then 
able to perform its biological function within the nucleus (Corbett and Silver, 1997; 
Kaffman and O'Shea, 1999; Nigg, 1997).
Nucleocytoplasmic Shuttling
Nuclear receptors, including the glucocorticoid receptor (GR), estrogen receptor 
(ER), PR, and recently TR have been shown to undergo rapid nucleocytoplasmic 
shuttling (Bunn et al., 2001; Newmeyer, 1993). These receptors localize to different parts 
of the cell at steady state. In the absence of hormone, GR, the mineralocorticoid receptor 
(MR) and possibly the androgen receptor (AR) are localized to the cytoplasm of the cell. 
In the presence of hormone, these receptors enter the nucleus and enhance transcription. 
On the other hand, the progesterone, estrogen, and thyroid hormone receptors are 
primarily localized to the nucleus in the absence of ligand and in the presence of ligand 
activate transcription. Interestingly, ER and PR are not associated with DNA in the 
absence of ligand while TR is bound to DNA. ER and PR only bind their target 
sequences in the presence of ligand (Hache et al., 1999; Tsai and O'Malley, 1994). These 
localizations are not absolute, however, and depend on the cell type. For example, in 
Xenopus oocytes, TR can be found in both the cytoplasm and the nucleus at steady state 
(Bunn et al., 2001).
All these receptors apparently contain NLSs allowing them to enter the nucleus 
and, once there, they interact with the DNA to turn on the appropriate genes based on the 
hormonal signal (Hache et al., 1999; Tsai and O'Malley, 1994). Interestingly, GR and PR
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contain multiple NLSs (Guichon-Mantel et al., 1996; Hache et al., 1999). In the presence 
of ligand, GR acts as a shuttling protein that continuously travels between the cytoplasm 
and the nucleus. The first NLS, NL1 is located in the C-terminal end of the DNA binding 
domain of GR and is the main signaling motif. However, a second ligand-dependent 
NLS, NL2, has been found in the ligand-binding domain of GR (Hache et al., 1999). As 
mentioned earlier, PR also has multiple NLS sequences. The first, a hormone- 
independent sequence, is found in the hinge region and is very similar to the classic NLS. 
A second NLS is located in the second zinc finger of the DNA binding domain. This 
signal is regulated by the mechanisms that control the activity of DNA binding. A third 
weaker ligand-dependent signal is present in the steroid-binding domain. In contrast, 
human AR has had only one NLS identified, a region of twenty amino acids. It is located 
in the hinge region of the receptor and has the same properties as the bipartite signal 
previously mentioned. Similarly, human ER contains a forty-eight amino acid sequence 
located in the hinge region between the DNA and hormone-binding domains (Guichon- 
Mantel et al., 1996).
Research has suggested that TR can follow a receptor-mediated pathway for 
import into the nucleus, although in Xenopus oocytes a co-existing passive pathway has 
been demonstrated (Bunn et al., 2001). Despite indirect evidence for a NLS in TR, it has 
proved difficult to define a NLS as both necessary and sufficient for nuclear localization. 
A basic sequence in the D domain, which is conserved in all TR iso forms, has been 
shown to target cytoplasmic proteins to the nucleus, albeit weakly, in that nuclear 
localization and retention were not complete (Dang and Lee, 1989). Other experiments, 
using various methods, have shown that this region is indeed important for import;
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however, by itself, it is not efficient at promoting nuclear import (Boucher et al., 1988; 
Lee and Mahdavi, 1993; Zhu et a l, 1998). Therefore, other factors not yet discovered 
must be involved in regulating TR subcellular movement (Bunn et al., 2001).
Phosphorylation o f transcription factors and viral proteins
The phosphorylation of transcription factors and viral proteins has been shown to 
be an important regulatory factor in many systems. For example, Kann et al. (1999) 
showed, using digitoniri permeabilized cell in vitro nuclear import assays, that only 
phosphorylated hepatitis B virus core particles were targeted to the nucleus. Nuclear 
uptake of the virus core particle was shown to involve a NLS-mediated pathway. They 
also demonstrated that the phosphorylated core particle interacts directly with nuclear 
pore complex proteins via a nuclear pore binding signal, and can inhibit nuclear import of 
other nuclear proteins by competing for these binding sites. In conclusion, the authors 
suggest that phosphorylation of the core subunit causes a conformational change that 
exposes the COOH-terminal NLS so that the phosphorylated residues are no longer 
accessible to phosphatases, allowing entry of the viral particle into the nucleus (Kann et 
al., 1999).
Similarly, it has been shown that nuclear import of Dorsal, a member of the Rel 
family of proteins in Drosophila, is regulated by phosphorylation (Drier et al., 1999). 
Dorsal is of prime importance in Drosophila development. This protein is involved in 
the formation of the ventral-to-dorsal nuclear gradient. Dorsal is normally found in the 
cytoplasm bound to the I-KB-related protein Cactus. In response to a ventral signal, 
signal-dependent phosphorylation of both Cactus and Dorsal leads to the degradation of
16
Cactus and nuclear targeting of Dorsal. This phosphorylation event is necessary for 
nuclear import and thus is vital to the development of the adult fly (Drier et al., 1999).
Phosphorylation has also been implicated as playing a role in regulating the 
nuclear import of NF-kB, another member of the Rel family of proteins. NF-kB is a 
transcription factor found in B cells, which are involved in the human inflammatory 
immune response. In this system, phosphorylation has been shown to be important as a 
method of masking and unmasking nuclear localization sequences (NLSs) (Moroianu,
1999). In the inactive state NF-kB is found in the cytoplasm, bound to the inhibitor I-kB, 
thus masking the NLS of NF-kB. Activation begins by binding of a bacterial 
lipopolysaccharide to a cell surface receptor. This binding initiates a signaling cascade, 
which eventually leads to the activation of IKKa, a serine-specific kinase. This kinase 
then phosphorylates two serine residues on I-kB, causing I-kB to dissociate from NF-kB. 
This dissociation unmasks the NLS, exposing it to the nuclear import machinery and thus 
allowing import of NF-kB into the nucleus (Moroianu, 1999).
Kaffman et al. (1998) demonstrated that the phosphorylated form of the 
transcription factor Pho4 could not bind to Psel, which is a member of the importin p 
family, and thus could not be imported into the nucleus. Pho4 is a yeast transcription 
factor required for phosphate starvation-specific gene expression. This protein is 
regulated by changes in the extracellular concentration of inorganic phosphate. Under 
conditions of high phosphate, Pho4 resides in the cytoplasm and is phosphorylated, thus 
resulting in repression of genes active under low phosphate conditions. However, under 
phosphate-starved conditions, Pho4 becomes dephosphorylated by inhibition of the
17
kinase responsible for the normal levels of phosphorylation. This unphosphorylated form 
is then able to bind to Psel and this complex is then transported into the nucleus.
Another study has shown that dephosphorylated NLS tagged-albumin conjugates 
were unable to undergo nuclear transport in digitonin-permeabilized cells (Mishra and 
Pamaik, 1995). This model is very effective because albumin does not have a NLS, 
allowing direct study of phosphorylation of specific sequences of the various NLSs. 
Dephosphorylation also prevented the conjugates from binding to the nuclear pore 
complex, an essential step in signal-mediated nuclear transport. Interestingly when the 
cells were treated with protein kinase C or A (PKC and PKA), the conjugates were 
phosphorylated and nuclear transport was restored.
Steroid receptor phosphorylation
Members of the steroid/thyroid hormone receptor superfamily are 
phosphoproteins. Many of their phosphorylation sites are serine and threonine residues; 
however, some members of the family can be phosphorylated at tyrosine residues 
(Weigel, 1996). Evidence for phosphorylation has been provided by experiments using 
several techniques, including altered mobility on a SDS-polyacrylamide gel, detection of 
phosphotyrosine using a phosphotyrosine specific antibody, and [3 2 P] labeling studies 
(Tsai and O'Malley, 1994). These studies have shown that phosphorylation may have a 
role in hormone binding, DNA binding, transcriptional activation, and nuclear import 
(specifically nucleocytoplasmic shuttling of GR) (Tsai and O'Malley, 1994), as described 
below.
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Role o f phosphorylation in hormone binding
Studies have shown that phosphorylation may play a role in hormone binding by 
nuclear receptors. For example, using in vitro analysis, Auricchio’s research group has 
shown that phosphorylation is involved in hormone binding of ER (Tsai and O’Malley, 
1994). They showed that treatment with nuclear phosphatase results in the loss of 
hormone binding. Furthermore, they demonstrated that treatment of ER with Ca2+ 
calmodulin kinase phosphorylates tyrosine residues, and restores the hormone binding 
activity of ER (Castoria et al., 1993). While these earlier studies suggested a role for 
phosphorylation in hormone binding, more recent work has suggested an altematative 
interpretation. The current belief is that members of the superfamily are typically basally 
phosphorylated. This phosphorylation level is then increased with ligand binding 
(Weigel, 1996). However, this new idea does not completely invalidate earlier work and 
a great deal of research continues on the subject.
Role o f phosphorylation in DNA binding
Phosphorylation has also been shown to have a role in DNA binding of nuclear 
receptors. Many of these studies have focused on ER and PR. For example, it has been 
shown that, upon treatment with estradiol, ER becomes phosphorylated in MCF-7 breast 
adenocarcinoma cells (Denton et al., 1992). They then treated these cells with a potato 
acid phosphatase. The result was a decrease in phosphorylation of ER as measured by 
decreasing 32P levels. They further demonstrated that the dephosphorylated receptor had 
a lower affinity for specific DNA binding sites. Other groups have reported similar 
results. Phosphorylating human ER on tyrosine 537 led to its dimerization with other
19
ERs in human MCF-7 cells. Further, in agreement with Denton et al. (1992), 
dephosphorylation caused a decrease in binding of ER to its specific response element as 
shown by electrophoretic gel mobility shift assays (EMSA) (Arnold et a l, 1995).
Studies with PR have yielded conflicting results. Using zinc finger mutants, 
Takimoto et al., (1992) demonstrated that hormone-induced phosphorylation of human 
PR includes DNA-independent and DNA-dependent stages. They proposed a three-stage 
cascade of phosphorylation. First, there is basal phosphorylation where low levels of 
phosphates are incorporated into the receptors. The second stage begins when hormone 
binding causes a conformational change exposing additional residues to phosphorylation. 
The third stage occurs when the receptor binds to DNA. Once again, this binding is 
proposed to cause a conformational change that exposes new residues for 
phosphorylation.
In support of DNA-dependent phosphorylation, Bagchi et al. (1992) reported that 
binding of PR to its specific response element occurs prior to phosphorylation. However, 
the authors reported that they saw no ligand-induced phosphorylation, suggesting that 
liganded receptor is not a prerequisite for DNA binding. They propose a model in which 
the receptor is synthesized and then complexed with heat shock protein 90 (hsp90) in the 
cytoplasm. Hormone binding causes a release of this complex, and PR forms a dimer and 
binds to its response element in the nucleus. Binding to DNA then induces 
phosphorylation of the receptor (Bagchi et al., 1992). Beck et al. (1992) provides 
additional evidence suggesting that phosphorylation is not necessary for DNA binding.
In this study, T47D breast cancer cells were treated with 8 -bromo-cAMP, an activator of 
cAMP-dependent protein kinases and okadaic acid which is a known inhibitor of proteins
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phosphatases 1 and 2 A. Neither compound modified the DNA binding activity of the 
receptor, as assayed by EMSA of whole cell extracts from treated and untreated cells.
Role o f phosphorylation in transcriptional activation
While the role of phosphorylation in hormone and DNA binding remains 
undecided, its role in nuclear receptor activation is becoming more firmly established. A 
number of steroid receptors have been utilized in these studies. While Beck et al. (1992) 
showed that phosphorylation did not alter the DNA binding affinity of PR, their results 
suggested that indeed phosphorylation enhanced transcription of target genes. In their 
study, both 8-bromo-cAMP and okadaic acid enhanced PR-mediated transcription 3 to 4 
fold in the presence of progestin. Furthermore, H8, a cyclic nucleotide-dependent protein 
kinase inhibitor, blocked gene expression in the presence of the hormone. Taken 
together, these results suggest a role for phosphorylation in activation of progestin- 
dependent gene expression by PR. Researchers working with ER have reported similar 
results. Mutagen studies have shown that serine 118 is important in transcriptional 
activation of human ER. Mutation of this residue to an alanine residue led to a reduction 
in ER-mediated gene transcription (Joel et al., 1998). In their study, the authors 
demonstrate that pp90rskl, a ribosomal kinase, phosphorylates human ER at serine 167. 
This phosphorylation was also shown to enhance transcription o f target genes (Joel et al., 
1998). Similarly, the human vitamin D receptor (VDR) has been shown to have 
enhanced transcriptional activity in the presence of casein kinase II (CK-II) (Jurutka et 
al., 1996). Thus, phosphorylation of members of the nuclear receptor superfamily seems 
to play a role in their ability to activate transcription.
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Role o f phosphorylation in nucleocytoplasmic shuttling
As previously mentioned phosphorylation seems to play an important role in the 
nuclear transport of many proteins. Since the steroid receptors are phosphoproteins and 
undergo nucleocytoplasmic shuttling, research on the role of phosphorylation in this 
phenomenon is receiving a great deal of attention. For example, numerous studies have 
suggested that phosphorylation regulates GR shuttling. GR distribution seems to be 
regulated by protein phosphatases 1 and 2 A and tyrosine kinases in rat fibroblasts 
(DeFranco et al., 1991). The authors showed that a high dose of okadaic acid leads to 
poor nuclear retention. Since okadaic acid is known to inhibit these two phosphatases, 
these findings suggest that phosphorylated GRs are not capable of recycling and remain 
cytoplasmic (DeFranco et al., 1991). Another paper demonstrating the importance of GR 
phosphorylation state on subcellular localization used digitonin-permeabilized cell 
nuclear export assays. In this study, tyrosine kinase inhibitors prevented GRs from being 
phosphorylated, leading to an inhibition of nuclear export (DeFranco, 1997).
TR Phosphorylation
TR, like its counterparts in the steroid receptor superfamily, is a phosphoprotein. 
Both rat and chicken TRa have a well-characterized casein kinase II phosphorylation site 
at serine 12 in the N-terminal region (Glineur et al., 1989; Goldberg et al., 1988). In 
addition, v-ErbA, a viral oncogenic homolog of chicken TRa, has a cAMP-dependent 
protein kinase A site at serines 28/29 (Glineur et al., 1990). Researchers have 
demonstrated that the oncoprotein must be phosphorylated for full biological activity as a 
transcriptional repressor, as kinase inhibitors reduce the function of v- ErbA (Glineur et
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al., 1990). In contrast, Katz et al. (1995) reported that phosphorylation of the TRa2 
variant in rats reduces its ability to bind to DNA. When TRa2 was dephosphorylated an 
increase in repressor activity was observed. Another report suggests that phosphorylation 
may be involved in regulating the levels o f TRpl in different cell types. Okadaic acid 
was used to enhance phosphorylation by inhibiting phosphatase activity. This increase in 
phosphorylation led to increased levels of TRpl, which the authors attributed to greater 
stability of phosphorylated TRpl in the various cell types (Ting et al., 1997).
Lin et al. (1992) showed that in addition to promoting receptor stability, 
phosphorylation led to an increase in the binding of TR to the TREs. The authors 
proposed a model in which phosphorylation allows TR to bind with nuclear accessory 
proteins by inducing a conformational change. Several other groups have suggested that 
phosphorylation may be involved in DNA binding of TR. However, Sugawara et al. 
(1994) and Bhat et al. (1994) reported conflicting results. Sugawara et al. (1994) 
reported no change in DNA binding of RXR/TRpl heterodimers after the 
phosphorylation of human TRpl(hTRpl). In contrast, Bhat et al. (1994) reported an 
increase in DNA-binding by heterodimers after phosphorylation of hTRp 1. Sugawara et 
al. (1994) did report an increase in homodimer binding of the phosphorylated receptor, 
while unphosphorylated TRpl bound DNA as a monomer. Adding confusion to the DNA 
binding issue, is a report that suggests phosphorylation does not alter the affinity of 
receptor dimers for DNA. However, this report also suggested that phosphorylation 
greatly inhibited the ability o f TR monomers to bind to DNA (Tzagarakis-Foster and 
Privalsky, 1998).
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Jones et al. (1994) used okadaic acid to increase phosphorylation of TR, and 
isoquinoline sulfonamide (H7), which inhibits phosphorylation by acting against a wide 
range of kinases, to test the effect of phosphorylation of TR on transcriptional activation. 
Okadaic acid, by inhibiting phosphatase activity augmented the transcriptional activity of 
a TRE-mediated reporter luciferase gene in the presence of T3 , in monkey kidney CV-1 
cells. Conversely, H7 lowered transcriptional activity as it inhibited kinase activity. 
Another report showed that T3 binding leads to a three-fold increase in phosphorylation 
of TRpl. Based on protease studies the authors suggested that phosphorylated TR 
undergoes a conformational change, which may play a role in transcriptional activation 
(Ting and Cheng, 1997). Thus, phosphorylation of TR is involved in regulating 
transcription. However, currently the mechanism is not yet understood. It is not clear 
whether phosphorylation is directly or indirectly affecting regulation through the receptor 
or the other proteins involved.
Use ofXenopus oocytes as a model system
Xenopus oocytes were first used for microinjection experiments in the 1970s. 
Since that time, this system has been used to study a number of mechanisms and 
important pathways, including characterization of protein kinases and their inhibitors as 
well as studies of the meiotic machinery (Lacal, 1999). Oocytes have been used to 
determine gene function, which has greatly enhanced our understanding of various 
secretory products, as well as aiding in the identification of many membrane receptors. 
Examples include characterization of the Na+ and K+ channels and the GAB A 
transporters. In addition, the Ras and Mos oncogenic pathways were first studied in
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Xenopus oocytes (Lacal, 1999). These studies were possible because the oocytes 
demonstrate a unique ability to transcribe and translate most injected foreign DNA and 
RNA. Their large size also makes them ideal for the recovery of proteins of interest 
(Lacal, 1999).
Oocyte microinjection assays are especially suited for TR research. Researchers 
have already used these types of assays to study the regulation of transcription by TR 
(Lacal, 1999; Nagl et al., 1995), and the ability to inject into both the cytoplasm and the 
nucleus makes this system ideal for studying nuclear import and export (Bunn et al., 
2001). Numerous examples can be found in the literature citing the use of oocyte 
microinjection to study nuclear import, including studies of RNA transport, as well as the 
transport of heat shock proteins (Lacal, 1999; Murdoch and Allison, 1996). Furthermore, 
since in oocytes TR is not entirely localized to the nucleus, factors that enhance nuclear 
retention can be studied.
Questions addressed in this thesis
As the preceding review has shown, phosphorylation has been implicated in many 
regulatory roles, not only in the function of nuclear receptors but for other proteins as 
well. Although there is a large body of literature available on the nuclear receptors, only 
a small amount is dedicated to TR. Much of the TR literature has focused on the effects 
of gene knockouts on murine development. This research has provided great insight into 
the many functions of TR; however, this type of research does not shed light on the 
various molecular interactions of TR, at the level of protein-protein and DNA-protein 
interactions. The eukaryotic cell has developed into a complex structure of many
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compartments. The trafficking of regulatory factors that occurs between compartments is 
vital to the development of an organism; thus understanding the nuclear import 
mechanisms of these factors is essential. Ultimately, to answer the fundamental question 
of how TRs regulate such a range of diverse functions in so many tissue types, additional 
molecular and cellular biology techniques will have to be applied. With these combined 
approaches many of the developmental questions will then be able to be answered. In 
this thesis research, three main questions were addressed.
1) Is nuclear TR phosphorylated in Xenopus oocytes?
2) Does phosphorylation of TR occur in the cytoplasm or the nucleus?
3) Is phosphorylation of TR an important mechanism for regulating its nuclear 
import and retention?
Materials and Methods
Gene constructs
pT3-rTRa, an expression vector containing rat TRal under the control of the T3 
RNA polymerase promoter, was a gift from M. Lazar (University of Pennsylvania School 
of Medicine, Philadelphia, PA). This plasmid was purified from host DH5a cells using 
Qiagen MidiPreps (Qiagen Inc., Valencia, CA) according to the manufacturer’s 
instructions.
35In vitro transcription/translation o f S-TRa
3 5 S-labeled TRa was synthesized using the TNT Rabbit Reticulocyte Lysate 
System (Promega, Madison, WI). The following reaction mixture was prepared: 25 pi 
TNT Rabbit Reticulocyte Lysate; 2 pi TNT Reaction Buffer; 1 pi TNT T3 RNA 
Polymerase; 1 mM Amino Acid Mixture, Minus Methionine; 40 U RNasin Ribonuclease 
Inhibitor; 1 pg ofpT3-rTRa DNA template; and 20 pCi L-[3 5 S]methionine (1000 
Ci/mmol, in vivo cell labeling grade; Amersham Life Science, Arlington Heights, IL), 
for a final reaction volume of 50 pi.
The reaction was incubated at 30°C for 90 minutes. 12% SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) and fluorography confirmed the presence of S-TRa.
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Xenopus oocyte microinjection
Microinjection needles were made from 1 mm glass capillaries using a Narshige 
PC-10 needle puller. After making the needle, the tip was broken to 20 pm diameter, 
confirmed using a stage micrometer. Microinjections were performed using a Pico-Pump 
(Medical Systems Corp., Greenvale, NY) with a pressure of 20 psi and a pulse time of 60 
msec, thus injecting a volume of 20 nl (-100 pg of S-TRa).
Surgeries were performed to remove ovarian lobes from adult Xenopus laevis. 
Procedures were approved by the Institutional Research on Animal Subjects Committee. 
Oocytes were processed as previously described (Allison et al., 1991; Allison et al.,
1993). The oocytes were transferred to small culture dishes with mesh along the bottom 
containing 0-R2 medium (82.5 mM NaCl, 2.5 mM KC1, 1.0 mM CaCh, 1.0 mM MgCh, 
1.0 mM Na2HP0 4 , 5.0 mM Hepes, 3.8 mM NaOH). Healthy stage V-VI oocytes 
(approximately 1 mm in diameter) were selected for microinjection. Oocytes have a 
pigmented animal pole and a lightly colored vegetal pole (Lacal, 1999). For nuclear 
injections the animal pole was turned upwards and the 2 0  nl sample was injected into the 
pole (Figure 4A). Placing the animal pole upwards provides an approximate location for 
the nucleus; this type of injection is a “blind” injection. A successful injection yields a 
red nucleus after dissection due to the presence of hemoglobin in the rabbit reticulocyte 
lysate. For cytoplasmic injections the vegetal pole was turned upward and the sample 
was injected into the pole (Figure 4B).
After injection, oocytes were incubated in 0-R2 solution containing 100 jxg/ml 
cycloheximide (Sigma Chemical Co., St. Louis, MO), which prevents de novo protein 
synthesis and thus prevents incorporation of excess 3 5 S-methionine into endogenous
Figure 4. Microinjection of Xenopus oocytes. A. Nuclear 
microinjection. B. Cytoplasmic microinjection.
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proteins. Cycloheximide does not interfere with nuclear import of proteins in Xenopus 
oocytes (Murdoch and Allison, 1996). The oocytes were left on ice for 15-20 minutes to 
promote wound healing, and were subsequently incubated at 20°C for various durations.
Dephosphorylation assay
3 5 S-TRa was microinjected into the cytoplasm of Xenopus oocytes, followed by 
incubation for 6  hours at 20°C. Subsequently, the oocytes were manually dissected in 
Nuclear Isolation Medium (NIM) (83 mM KC1; 17 mM NaCl; 10 mM Tris, pH 7.2; 1 
mM phenylmethylsulfonyl fluoride [PMSF]). Nuclei were separated from the cytoplasm 
by making a small tear in the animal pole. Nuclei were then gently removed from the 
cytoplasm. Six nuclei and six cytoplasms were pooled per sample. The cytoplasms were 
homogenized in Homogenization Buffer (1% Triton X-100; 100 mM NaCl; 20 mM Tris- 
HC1, pH 7.6; 1 mM PMSF). The cytoplasms were centrifuged at 9,000 x g for 5 minutes 
to pellet the yolk and pigment. The supernatant was added to 5 vol acetone and allowed 
to precipitate overnight at -80 °C.
The nuclei were brought to a final volume of 12 pi with NIM. The 
dephosphorylation reaction was prepared as follows for a final volume of 40 pi: 12 pi 
nuclear extract; 20 U Calf Intestinal Alkaline Phosphatase (Promega); IX 
Dephosphorylation Buffer (Promega). A mock reaction was prepared with nuclear 
extract and IX Dephosphorylation Buffer. Both the dephosphorylation and mock 
reactions were incubated at 37°C for 1 hour. Samples were then precipitated overnight in 
5 vol acetone. Both fractions were centrifuged and the acetone was removed. The 
sample pellets were allowed to air dry, and then resuspended in 20 pi of IX SDS-PAGE 
Sample Buffer (125 mM Tris, pH 6 .8 ; 1% SDS; 5% glycerol; 0.005% bromophenol blue;
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10 mM DTT), and boiled for 3 minutes. Samples were separated by 12% SDS-PAGE. 
The gel was then fixed for at least 30 minutes in isopropanol: H2 O: acetic acid (25:
65:10). After fixing, the gel was transferred to Amplify (Amersham) and was agitated for 
30 minutes. Amplify increases the detection efficiency of 35S by converting the beta 
emissions to light when exposed to X-ray film. The gel was then dried for one hour at 
80°C under vacuum using a BioRad Gel Dryer (Hercules, CA). The film was exposed to 
Kodak X-OMAT film and stored at -80°C for 2 weeks. The film was then developed 
using a Konica X-ray film processor.
Treatment o f oocytes with Okadaic Acid (OA), and Isobutyl-methyl-xanthine (IBMX) 
3 5 S-TRa was microinjected into the cytoplasm o f Xenopus oocytes. After 
injection the oocytes were incubated in 0-R2, cycloheximide, and dimethylsulfoxide 
(DMSO) as the control. DMSO is the solvent vehicle for the various compounds and as 
such the same percentage of DMSO was added to the control as was added to the various 
treatments. Other oocytes were incubated for 3 hours at 20°C in either OA (100 pM) or 
IBMX (125 pM). H7, an inhibitor of various kinases, and forskolin, a PKA activator 
were used; however, both compounds proved to be toxic to the oocytes and the 
experiments were discontinued. After incubation, oocytes were dissected in ice cold 1 % 
trichloroacetic acid (TCA) or, in later experiments, ice cold Nucleus Isolation Buffer 
(NIB) (25 mM Tris, pH 8.0; 10% glycerol; 5 mM MgCh; 2 mM DTT). Six nuclei and 
six cytoplasms were pooled separately and homogenized in Homogenization Buffer. The 
cytoplasms were centrifuged at 9000 x g and the supernatant was added to 5 vol acetone. 
The nuclei and cytoplasms were processed in the manner previously described. The X-
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ray films were scanned, and the bands quantified using Scion Image Analysis software 
(Scion Corporation, Frederick, MD). Replicate experiments were performed and 
treatments were then compared using the Student’s t test to determine significance of the 
differences between the control and experimental data sets (with n representing the 
number of samples of six pooled cytoplasms or nuclei).
Compartment studies
3 5 S-TRa was microinjected into the cytoplasm or the nucleus of Xenopus oocytes. 
The oocytes were then either immediately dissected in NIB or were allowed to incubate 
at 20°C for 3 hours prior to dissection. A successful cytoplasmic injection was indicated 
by the absence of a red nucleus, while a successful nuclear injection presented a red 
nucleus. All samples were processed as described above.
SDS-PAGE
Before preparing the separating gel, the gel plates, spacers, and combs of the 
BioRad Mini Protean ii apparatus (Hercules, CA) were cleaned with 95% ethanol. The 
gel box was then set up according to the manufacturer’s instructions. The gel solution 
(10-12% acrylamide mix [29:1 acrylamide: bisacrylamide; BioRad Laboratories], 375 
mM Tris, pH 8 .8 , 0.1% SDS, 0.1% ammonium persulfate [APS], and 0.04% TEMED) 
was poured between the gel plates. Water-saturated butanol was added to the top of the 
gel to prevent oxygen from interfering with polymerization. The separating gel was 
allowed to polymerize for 30 minutes.
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After the separating gel polymerized, the butanol was removed by rinsing with 
water. The stacking gel was then prepared by mixing 5.1% acrylamide mix, 0.13 M Tris, 
pH 6 .8 , 0.1% SDS, 0.1% APS, and 0.1% TEMED. This solution was poured on top of 
the separating gel and the comb was inserted. The stacking gel was allowed to 
polymerize for 30 minutes. Following polymerization, the comb was removed and the 
gels were assembled in the gel apparatus. SDS-PAGE Running Buffer (192 mM glycine; 
25 mM Tris, pH 8.2; 3 mM SDS) was poured into inner and outer sections of the gel 
apparatus.
Protein pellets were resuspended in 20 pi o f IX SDS-Page Sample Buffer. All 
gels contained one lane of BioRad Kaleidoscope Pre-stained Standards, so that the size of 
the proteins could be compared with the known sizes of the proteins in the standard. All 
samples were incubated in a boiling water bath for 3 minutes, and then loaded into the 
lanes of the gel using BioRad Gel Loading Tips. Samples were electrophoresed at 150 V 
until the bromophenol blue dye reached the end of the gel plates.
In vitro phosphorylation o f TRa
TRa was phosphorylated under the following reaction conditions in a total 
volume of 25 pi: 2 pi Casein Kinase II Buffer (New England Bio Labs, Beverly, MA) (20 
mM Tris-HCl; 50 mM KC1; 10 mM MgCk); 1.25 pi of 1 pM ATP; 500 U Casein Kinase 
II (New England BioLabs); 10 pCi Easytides y 3 2P-ATP (Perkin Elmer Life Sciences 
(NEN); 3000 Ci/mmol) or 10 pCi Redivue y 3 2P-ATP (Amersham; 3000 Ci/mmol); and 5 
pi 3 5 S-labeled TRa in TNT rabbit reticulocyte lysate. The appropriate mock reaction was 
also prepared using 5 pi of rabbit reticulocyte lysate in place of the 3 5 S-labeled TRa.
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The reaction mixture was incubated for 30 minutes at 30°C, followed by the 
addition of 25 pi o f 2X SDS-PAGE Sample Buffer to the reaction. Samples were 
analyzed by 12% SDS-PAGE and fluorography. Two X-ray films were placed over the 
dried gel for about 3 hours. The use of two films provides a method to visualize not only 
phosphorylated TRa but also the 3 5 S-labeled TRa. The 32P that is incorporated into the 
phosphorylated TR exposes both films, however, the 3 5 S-labeled TR only exposes the 
film closest to the dried gel. This method takes advantage of the fact that 32P is a stronger 
beta emitter and thus penetrates both films.
Microinjection o f phosphorylated TRa
Phosphorylated 3 5 S-labeled TRa was injected into the cytoplasm o f Xenopus 
oocytes. The oocytes were then either immediately dissected or allowed to incubate at 
20°C for 3 hours and were then manually dissected and analyzed for nucleocytoplasmic 
distribution as previously described.
Mutagenesis
To introduce mutations into TRa, the Transformer Site-Directed Mutagenesis Kit 
(Clontech Laboratories, Inc.) was used. The goal of this procedure was to introduce three 
separate mutations into TRa at position 12, which is normally a serine residue that is 
phosphorylated by casein kinase II. Unfortunately, despite numerous attempts this 
procedure was unsuccessful at introducing the mutations, and, consequently, this strategy 
was abandoned.
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A PCR based strategy was then used to introduce the three mutations at position 
12 as well as a deletion of positions 1-12. PCR was a viable option since the position of 
interest was close to the N terminus. Five primers were designed in order to introduce the 
mutations and to create restriction sites for subcloning. The right primer introduced a 
BamHI restriction site while the four different left primers introduced a SacI restriction 
site; bold letters indicate the introduced mutations. The right primer was as follows: 5’- 
GGT GGA TCC TTA GAC TTC CTG ATC C. The serine to alanine primer used was as 
follows: 5’- C CGA GCT CGA ATG GAA CAG AAG CCA AGC AAG GTG GAG 
TGT GGG GCC GAC CCA. The serine to threonine primer used was as follows: 5’- C 
CGA GCT CGA ATG GAA CAG AAG CCA AGC AAG GTG GAG TGT GGG ACC 
GAC CCA. The serine to glutamic acid primer used was as follows: 5’- C CGA GCT 
CGA ATG GAA CAG AAG CCA AGC AAG GTG GAG TGT GGG GAG GAC CCA. 
The deletion mutant primer used was as follows: 5’- C CGA GCT CGA ATG GAC CCA 
GAG GAG AAC.
The following PCR reaction was set up in a total volume 50 pi: 1.25 pi o f 20 pM 
left primer (Gene Link Inc., Foster City, CA); 1.25 pi o f 20 pM right primer (Gene Link 
Inc.); 5.0 pi 10X Pfu Buffer (Stratagene, LaJolla, CA); 1.0 pi of 10 mM PCR nucleotide 
mix (Stratagene); 2.5 U of Turbo Pfu DNA polymerase (Stratagene); 10 ng pT3-rTRa. 
PCR was then performed in the Gene Amp PCR system 2400 (Perkin Elmer, Foster City, 
CA) under the following parameters, beginning with 95°C for 5 minutes. The next cycle 
was performed 30 times: 95 °C for 30 seconds, 65 °C for 1 minute (55 °C for the glutamic 
acid mutant), and 72 °C for 1.5 minutes. The following cycle was performed one time: 95
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°C for 30 seconds, 65 °C for 1 minute (55 °C for the glutamic acid mutant), and 72 °C for 
7 minutes.
Following PCR, agarose gel electrophoresis was used to confirm the presence of 
PCR products. The PCR products were then purified using the Qiagen PCR Purification 
Kit according to the manufacturer’s instructions. Sequential restriction digests were then 
performed on the purified PCR product and the pGEM 4Z vector (Promega). The first 
restriction digests were conducted in a final volume of 40 pi with either 4 pg pGEM 4Z 
vector or 30 pi purified PCR product, and 40 U SacI (New England BioLabs), 4 pi 1 OX 
NeBuffer I, and 4 pi 1 OX BSA (New England BioLabs). The reactions were then 
incubated for 3 h at 37°C. These reactions were then purified using the Qiagen PCR 
Purification Kit according to the manufacturer’s instructions. Following the purification 
a second restriction digest was performed: 30 pi purified DNA from first digest, 40 U 
BamHI (New England BioLabs), 4 pi 1 OX BamHI buffer, 4 pi 1 OX BSA (New England 
BioLabs). This reaction was then incubated overnight at 37°C.
After incubation overnight, 4 pi of 1 OX-glycerol dye (0.2 M EDTA, 50% 
glycerol, 0.25% Bromophenol Blue, 0.25% Xylene cyanol) were added to each digest and 
samples were electrophoresed on a 1% agarose gel. The gel was stained with 
0.1 pg/ml EtBr and the bands were visualized on a UV transilluminator and excised. The 
excised bands containing the DNA were purified using the Qiagen Gel Purification Kit 
according to the manufacturer’s instructions. The digested pGEM 4Z vector and the 
digested PCR product were ligated (3:1 vector: insert ratio) together in the following 
reaction in a total o f 10 pi: 100 ng digested pGEM 4Z, 133 ng digested PCR product, 3 U
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T4 DNA ligase (Promega), and 1 jul 10X ligase buffer. The reaction was then incubated 
overnight at 16°C.
Following the overnight ligation, XL 10-Gold ultracompetent cells (Stratagene) 
were transformed with 5 pi of the ligation reaction according to the manufacturer’s 
instructions. The transformed cells were then plated and grown overnight at 37 °C on LB 
plates containing ampicillin and X-gal. White colonies, containing the insert, were 
selected and cultured overnight. DNA was extracted and purified from these cultures 
using the Qiagen Mini Prep kit according to the manufacturer’s instruction. A 0.7% 
agarose gel was used to screen for the presence of the insert by comparing the size of 
nonrecombinant pGEM4Z with recombinant pGEM4Z containing the mutant TRa insert. 
The successfully ligated products ran at a slower rate on the gel than the faster band 
representing the nonrecombinant vector. SacI/BamHI digests were then performed to 
confirm the correct orientation of the insert in the recombinant plasmids.
DNA Sequencing
To confirm the success of the PCR-based mutagenesis of TRa, manual dideoxy 
sequencing was performed using the Sequenase Version 2.0 DNA sequencing kit (USB, 
Cleveland, OH). Figure 5 shows the results of the sequencing reactions for the threonine 
and alanine mutants, which clearly contain the appropriately altered sequence at the 
codon for amino acid 12. Due to the guanosine-rich-sequence in the region of interest of 
the glutamic acid mutant, the sequence was ambiguous; however, the mutation was 
presumed correct due to the absence of the wild type sequence (data not shown). Before 
preparing the gel and reactions, the plates were cleaned with Alconox, 70% ethanol, and
37
acetone. After cleaning the plates, one side of each plate was coated with Sigmacote 
(Sigma). The base and side spacers were then cleaned with 70% ethanol. The spacers 
were arranged between the gel plates to prevent leaks and then the plates and spacers 
were clamped together.
When the plates were ready, the gel solution was prepared. The gel was made as 
followed: 42 g urea, 10 ml 1 OX TBE, 15 ml of 40% Acrylamide Stock (19:1 acrylamide : 
bisacrylamide, BioRad), and brought to a final volume of 100 ml with d d ^O . The 
solution was then heated in a 37°C water bath for 10 minutes, filtered with a 0.22 micron 
filter, and brought to a final volume of 100 ml. The solution was then left on ice for 5 
minutes. Immediately prior to pouring the gel, 800 pi 10% APS and 50 pi TEMED were 
added to the solution.
While the gel polymerized the pGEM4Z-TRa mutant constructs were prepared 
for sequencing. The DNA was denatured in the following reaction: 1 pg of DNA and 1 
pi of 2N NaOH. The reaction was briefly centrifuged and allowed to incubate at room 
temperature for 5 minutes. To the above reaction, 5 pi of 4 M NEfiAc, pH 7.0, and 50 pi 
of 100 % ethanol were added. After mixing, the DNA was allowed to precipitate for 1 h 
at -20°C. The reaction was then centrifuged at 12,000 rpm for 25 minutes at 4°C in a 
5417R centrifuge (Eppendorf, Westbury, NY). The supernatant was discarded and the 
pellet washed with 25 pi of 70% ethanol. The DNA was then centrifuged for 5 minutes 
at 4°C , the supernatant removed, and the pellet air dried briefly.
The annealing reaction was then prepared as follows: 5 pi TE, pH 8.0, 2 pi 5X 
Sequenase buffer, and 30 ng of the SP6  promoter primer (Promega). The reaction 
mixture was resuspended 40X on ice, and placed in water heated to 65°C. The samples
were then allowed to cool to room temperature in the water, usually for about 20-30 
minutes. The sequencing reaction was prepared as follows while the annealing reaction 
mixture cooled: 1 pi DTT, 0.4 pi 5X labeling mixture, 1.6 pi H2 O, 0.5 pi 3 5 S-adATP (10 
pCi/pl, 1000 Ci/mmol, Amersham), and 0.25 pi Sequenase. To each tube of annealed 
DNA, 3.75 pi of the sequencing reaction was added and allowed to incubate for 7 
minutes at room temperature. During this time 2.75 pi o f dideoxynucleotides were added 
to the wells of microtiter plates (U-shaped wells, Nunc). Following the incubation, 3.25 
pi of the sequencing reaction were added to each well containing the dideoxynucleotides. 
The samples were then incubated in a 37°C water bath for 5 minutes. Subsequently, the 
microtiter plates were placed on ice and 4 pi o f stop buffer were added to each well.
Prior to loading the samples, the sequencing apparatus (BioRad) was run for 1 h 
at 62W to pre-warm the gel. Samples were then heated for 1.5 minutes at 80°C, and 4 pi 
of each sample were electrophoresed for 90 minutes at 62 W. After completion of the 
run, the plates were removed from the sequencing apparatus and separated. Whatman 
paper was placed over the gel to remove it from the plate. The gel was then covered with 
Saran Wrap and dried under vacuum at 80°C for 2 h on a BioRad Gel Dryer. The dried 
gel was allowed to cool under vacuum, and was then exposed to X-ray film overnight at 
room temperature. The next day the film was developed using a Konica X-ray film 
processor and the results were analyzed. Having confirmed the mutant sequence, the 
mutant TRa expression vectors that were generated by PCR-based mutagenesis were 
named as follows: pGEM4Z-rTRa (ala), pGEM4Z-rTRa (thr), pGEM4Z-rTRa (glu), for 
the substitution of alanine, threonine, or glutamic acid at position 1 2 , respectively; and 
pGEM4Z-rTRa A12, for the mutant with a deletion of the first 12 amino acids.
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Microinjection o f TRa mutants
•7 r
S-labeled mutant TRs were generated by in vitro transcription/translation as 
described earlier, using pGEM4Z-rTRa (ala), pGEM4Z-rTRa (thr), pGEM4Z-rTRa 
(glu), and pGEM4Z-rTRa A12 expression vectors as templates. The 3 5 S-labeled mutant 
TRs were injected into the cytoplasm o f Xenopus oocytes. The oocytes were allowed to 
incubate at 20°C for 3 h and were then manually dissected and analyzed for 
nucleocytoplasmic distribution as previously described.
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Figure 5. Manual sequencing of TRa and mutants. A. Wild type 
serine (TCA) B. Threonine mutant (ACC) C. Alanine mutant (GCC). 
Blue arrows indicate the codon for the amino acid at position 12.
Results
A phosphorylatedform o f TRa is present in the nucleus ofXenopus oocytes
Prior Xenopus oocyte microinjection studies on nuclear import characteristics of 
TRa showed the very interesting finding that TRa recovered from nuclear fractions has a 
slightly altered mobility on denaturing SDS polyacrylamide gels when compared to TRa 
recovered from the cytoplasm (Fig 6 A). The nuclear TR band has an upward shift 
indicating slower movement through the gel matrix. Such an upward mobility shift often 
represents the phosphorylated form of a protein (Ronchini and Capobianco, 2000; 
Savouret et al., 1994; Tsai and O'Malley, 1994). Thus, it was of interest to determine 
whether the altered mobility of TRa was due to phosphorylation of nuclear TRa.
In order to assess the phosphorylation state of nuclear TR, 3 5 S-TRa was microinjected 
into the cytoplasm of Xenopus oocytes, and the oocytes were incubated 3 h to allow 
sufficient time for nuclear import of TRa. A time of 3 h was chosen based on other 
injection studies, which varied the incubation time. These experiments showed that 
nuclear import reached steady-state after 3 h (data not shown). The ability to dissect 
oocytes and separate the nucleus from the cytoplasm makes it possible to manipulate both 
fractions. Thus, nuclear samples were treated with alkaline phosphatase or with a mock 
treatment consisting of buffer alone, while cytoplasmic fractions remained untreated. 
Alkaline phosphatase dephosphorylates proteins (DeFranco et al., 1991; Sugawara et al.,
1994). Figure 6 B shows that TRa recovered from nuclear samples treated with alkaline
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Figure 6(A). Nucleocytoplasmic distribution of TRa in 
Xenopus oocytes. Xenopus oocytes were cytoplasmically 
injected with 35S-TRa. After 3 h incubation at 20°C, the oocytes 
were manually dissected into cytoplasmic (C) and nuclear (N) 
fractions. Proteins were separated by 12% SDS-PAGE, followed 
by fluorography. (B) A phosphorylated form of TRa is present 
in the nucleus of Xenopus oocytes. Xenopus oocytes were 
cytoplasmically microinjected with 35S-TRa. After 3 h 
incubation at 20°C, oocytes were manually dissected and proteins 
extracted from 6 cytoplasmic (C) or nuclear fractions. Nuclear 
fractions were treated with alkaline phosphatase (A) (lanes 3 and
7) and incubated for 1 h at 37°C or were mock-treated with buffer 
alone (M) (lanes 2 and 6). Cytoplasmic fractions (lanes 1,4,5 and
8) were left untreated. Proteins were separated by 12% SDS- 
PAGE, followed by fluorography.
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phosphatase had the same mobility as TRa recovered from untreated cytoplasmic 
samples (compare lanes 3 and 7 with lanes 1, 4, 5 and 8 ). The mock-treated samples 
(lanes 2 and 6 ) maintained the same mobility as untreated nuclear samples (Fig 6 A, lanes 
1 and 4), and show altered mobility of nuclear TRa compared with cytoplasmic TRa. 
These data suggest that a phosphorylated form of TRa is present in the nucleus of 
Xenopus oocytes.
The phosphorylation state o f  Xenopus oocytes modulates the nuclear distribution o f TRa 
The above results suggest that TRa recovered from the nucleus of Xenopus 
oocytes is phosphorylated. In order to assess the importance of phosphorylation in the 
nuclear localization of TRa, the phosphorylation state of the
oocyte was manipulated. 3 5 S-TRa was microinjected into the oocyte cytoplasm and three 
treatments were administered during the 3 h incubation period. One group was treated 
with IBMX, while another group was treated with okadaic acid. The third group was the 
control, which was incubated in an equivalent amount of the solvent DMSO. Both IBMX 
and okadaic acid are known to enhance the general phosphorylation state of cells (Bhat et 
al., 1994; Jones et al., 1994); IBMX acts as a phosphodiesterase inhibitor and protein 
kinase A activator, while okadaic acid prevents the activity of both phosphatase 1 and 2 A 
(Ting et al., 1997).
Figure 7 A shows the results of these experiments. In the presence of IBMX, 
nuclear localization of TRa was enhanced when compared with the nucleocytoplasmic 
distribution of TRa in untreated oocytes (compare lanes 2 and 4). In the absence of 
IBMX, on average, 33% of cytoplasmically injected 3 5 S-TRa was localized to the oocyte
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Figure 7(A). The phosphorylation state of Xenopus oocytes 
modulates the nuclear distribution of TRa. Oocytes were 
cytoplasmically injected with 35S-TR and incubated for 3 h at 
20°C without (lanes 1 and 2) or with IBMX (125|uM) (lanes 3 
and 4). The oocytes were manually dissected into cytoplasmic 
(C) and nuclear (N) fractions, and analyzed as described in Fig 6. 
Representative results are shown. (B) Summary of nuclear 
distribution of TRa in IBMX-treated Xenopus oocytes. Films 
were scanned and the percent of nuclear TR was quantified by 
densitometry, using Scion imaging software. A student t-test was 
performed. Untreated, n=13; IBMX-treated, n=17 (where “n” 
represents the number of six pooled cytoplasms or nuclei).
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nucleus. After treatment with IBMX, on average, the amount of 3 5 S-TRa localized to the 
nucleus after cytoplasmic injection increased significantly to 43% (P < 0.02) (Fig 7B). A 
similar trend was observed when nuclear import assays were carried out in the presence 
of okadaic acid (data not shown). However, okadaic acid increased oocyte mortality. 
Thus, insufficient replicates were obtained for statistical analysis. In summary, taken 
together, these data suggest that phosphorylation plays a role in the nuclear import and/or 
nuclear retention of TRa.
Phosphorylation/dephosphorylation o f TRa in Xenopus oocytes is a rapid process
Having shown that the nucleocytoplasmic distribution of TRa can be manipulated 
by altering the phosphorylation state of the oocyte, it was of interest to determine the 
length of time necessary not only for phosphorylation but for transport into the nucleus. 
Once again, the Xenopus oocyte system was utilized. One group of oocytes was 
cytoplasmically microinjected with 3 5 S-TRa, a second was microinjected into the 
nucleus. A successful nuclear injection was determined by the presence of a red nucleus 
after manual dissection. The presence of a red nucleus indicated that the needle 
penetrated the nucleus and successfully injected the red lysate containing the 
3 5 S-TRa. Within each of these treatments two incubation times were employed. Some 
oocytes were manually dissected immediately after microinjection. The remainder were 
incubated for 3 h at 20°C prior to dissection. The oocytes were then processed as 
previously described.
Figure 8  presents the results of this experiment. After immediate dissection, 
cytoplasmically microinjected TRa remained primarily in the cytoplasm, and showed the
46
faster mobility by SDS-PAGE indicative of unphosphorylated TRa (Fig 8 A, lanes 1 and
2). In a few samples a very small fraction of TRa localized to the nucleus and showed 
the slower mobility by SDS-PAGE indicative of phosphorylated TRa (data not shown). 
This result suggests that the changes in phosphorylation state of TRa can occur quite 
rapidly. After 3 h, 36% of TRa localized to the nucleus, and, as expected, showed an 
altered mobility compared with cytoplasmic TRa (lanes 3 and 4). Nuclear 
microinjections yielded varying results. After immediate dissection, TRa remained 
largely nuclear in all samples and showed the slower mobility indicative of 
phosphorylated TRa (lanes 5 and 6 ). However, in some samples a small fraction of TRa 
either leaked into the cytoplasm from the injection site or was rapidly exported from the 
nucleus. This cytoplasmic TRa showed the faster mobility indicative of 
unphosphorylated TRa.
Interestingly, in one set of nuclear samples, TRa did not show an altered 
mobility; however, this result was not seen in any of the replicate experiments. This 
observation could be the result of variability in metabolic activity seen between batches 
of oocytes from different frogs, as well as the variability in the length of time taken for 
the “immediate” dissection. While the dissections occurred within an average of ten 
minutes, they certainly did not all occur at the same instant since the dissections were 
done manually. Since the changes in phosphorylation state appear to occur very rapidly, 
the window to observe the shift in mobility could certainly be missed in individual 
oocytes. This point seems to be supported by observations of oocytes that were allowed 
to incubate for 3 h after microinjection of TRa into the nucleus. Microinjected TRa 
remained primarily nuclear, with a small percentage of TRa localized in the cytoplasm
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Figure 8. (A) Phosphorylation/dephosphorylation of TRa in Xenopus 
oocytes occurs rapidly. Oocytes were cytoplasmically injected with 35S-TRa 
and were dissected immediately (lanes 1 and 2), or were incubated for 3 h at 
20°C and then manually dissected (lanes 3 and 4). Alternatively, oocytes were 
injected into the nucleus and were dissected immediately (lanes 5 and 6), or 
were incubated for 3 h at 20°C and then manually dissected (lanes 7 and 8) 
into cytoplasmic (C) and nuclear (N) fractions, and analyzed as described in 
Fig 6. Representative results are shown (n=34). (B) 35S-TRa added to oocyte 
extracts changes phosphorylation state. Uninjected oocytes were manually 
dissected into cytoplasmic (C) and nuclear fractions (N). Following 
dissection, S-TRa was added to both cytoplasmic and nuclear extracts. 
Proteins were acetone-precipitated and analyzed by SDS-PAGE and 
fluorography.
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(lanes 7 and 8 ). All the samples of nuclear TRa showed an altered mobility by SDS- 
PAGE, compared with the samples of TRa that had been exported to the cytoplasm. In 
summary, taken together, these studies suggest that phosphorylation/dephosphorylation 
of TRa is a rapid process and is complete after 3 h.
Further support for rapid changes in the phosphorylation state of TRa can be seen 
in Fig. 8 B. Cytoplasmic and nuclear extracts were prepared from uninjected Xenopus 
oocytes (lanes 1 and 2). Subsequently, 3 5 S-TRa was added to both extracts. Proteins 
were then precipitated overnight in acetone. The extracted proteins were separated by 
SDS-PAGE and analyzed by fluorography. Interestingly, 3 5 S-TRa added to the nuclear 
extract showed an altered mobility when compared to the 3 5 S-TRa added to the 
cytoplasmic extract. There are at least two possible interpretations of this data. First, the 
rabbit reticulocyte lysate used for in vitro translation of 3 5 S-TRa, is known to have some 
kinase activity and could be phosphorylating TRa (Ohno et al., 2000; Promega, 2000).
In this scenario, the cytoplasmic extract must contain phosphatases, which rapidly 
dephosphorylate TRa and alter the mobility of TRa in the cytoplasmic extract when 
compared to TRa in the nuclear extract where phosphatases are absent or in low 
amounts. A second possibility is that the rabbit reticulocyte lysate does not 
phosphorylate TRa. This scenario would suggest the presence of kinases in the nuclear 
extract, which rapidly phosphorylate TRa and thus cause the mobility shift. 
Distinguishing between these two possibilities will require further experimentation. It 
should also be noted that these scenarios may not be mutually exclusive. Eukaryotic cells 
are compartmentalized and contain different sets of proteins in each compartment to 
perform different functions. Thus, the cytoplasm may contain an overall phosphatase
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activity while the nucleus may contain an overall kinase activity. The data presented here 
do not rule out this possibility. Regardless of which scenario is correct, these findings 
demonstrate the important point that changes in the phosphorylation state of TRa in 
Xenopus oocytes occur rapidly, within minutes.
Microinjection o f in vitro-phosphorylated TRa
The results of the nuclear import assays suggested that the general 
phosphorylation state of the oocyte is important for the nuclear localization of TRa, and 
that changes in the phosphorylation state of TRa in oocytes occur rapidly. Thus, it was 
of interest to attempt to manipulate the phosphorylation state of TRa itself in vitro, and 
then to determine the effect of microinjecting in v/Zro-phosphorylated TRa on nuclear 
import and nuclear retention. As stated in the Introduction, the nuclear receptors are 
phosphoproteins. These receptors have been extensively studied and many of the 
phosphorylation sites have been identified. Rat TRa has a well-characterized 
phosphorylation site found at serine 12, which is phosphorylated by casein kinase II 
(Glineur et al., 1989; Goldberg et al., 1988). Interestingly, TRs isolated from chicken 
have more than one well-characterized phosphorylation site and these additional residues 
(serine 28,29) are phosphorylated by protein kinase A (Glineur et al., 1989; Tzagarakis- 
Foster and Privalsky, 1998). To ensure that serine 12 was the residue phosphorylated, 
two in vitro reactions were performed using both casein kinase II and protein kinase A to 
test the ability of each kinase to phosphorylate rat TRa in vitro. The results from these 
control experiments showed that only casein kinase II phosphorylated TRa (data not 
shown), suggesting that indeed serine 1 2  was being correctly targeted since this residue
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has been shown to be phosphorylated by casein kinase II. Thus, for subsequent 
experiments, 3 5 S-TRa was incubated with casein kinase II and y32P ATP for 30 minutes. 
This phosphorylation reaction allowed for the incorporation of the second label to the 
protein at serine 12. The 3 5 S3 2 P-TRa was micro injected into the cytoplasm of Xenopus 
oocytes. After a 1 h or 3 h incubation, the oocytes (n=36) were manually dissected and 
proteins extracted from the nuclear and cytoplasmic fractions. The proteins were then 
separated by SDS-PAGE, and dried gels were exposed to two X-ray films. Using two 
films provides a method to visualize both the phosphorylated and unphosphorylated 
forms, as the 32P will expose both films while the 35S will only expose the film closest to 
the dried gel (Murdoch and Allison, 1996).
39Unfortunately, this method proved to be ineffective in that P-TRa was 
undetectable in the proteins recovered from the oocytes, although the 3 5 S-TRa was 
detectable. This result was surprising since 3 2 P-TRa bands could be detected after the 
phosphorylation reaction (data not shown). However, the rabbit reticulocyte lysate used
i f
in the transcription/translation reaction to produce S-TRa contains a number of 
abundant proteins that can be phosphorylated (Promega, 2000). Multiple bands were seen 
on both films after the phosphorylation reaction, suggesting that a large percentage of the 
32P label was incorporated into these other proteins. Furthermore, since only a small 
amount of TRa is translated using this in vitro system, and only a small amount of 
protein was injected into the oocytes, it is possible that, in combination with inefficient
  39
labeling of TRa, the amount of P-TRa recovered from each fraction was below the 
sensitivity limits of the X-ray film. The possibility also remains that after injection TRa 
was dephosphorylated and then re-phosphorylated with non-radioactive phosphorus
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within the oocytes, making it impossible to visualize phosphorylated TR by this method. 
This method of in vitro phosphorylation may prove useful once a substantial amount of 
purified TRa can be produced by over-expression in bacteria, after construction of an 
appropriate expression vector.
Phosphorylation o f TRa at serine 12 is not required for nuclear import or nuclear 
retention
Having shown that nuclear TRa is phosphorylated and that IBMX significantly 
enhances the nuclear localization of TRa by altering the phosphorylation state of the 
oocyte, it was of interest to determine which phosphorylation site in TRa is important for 
nuclear import and nuclear retention of TRa. As stated earlier, serine 12 is a well- 
characterized phosphorylation site and thus was chosen as the site to analyze (Glineur et 
al., 1989; Goldberg et al., 1988). Four mutant expression vectors for TRa were 
constructed; a deletion mutant which had the sequence coding for the first 1 2  amino acids 
deleted and three mutants with nucleotide substitutions converting the codon for serine to 
codons for alanine, threonine, or glutamic acid, respectively. These latter three mutations 
were chosen for the following reasons: 1 ) alanine residues cannot be phosphorylated and 
thus test the importance of phosphorylation at this site, 2 ) threonine residues can be 
phosphorylated and thus test whether it is a requirement for a serine at this position, and, 
3) glutamic acid residues cannot be phosphorylated but mimic the negative charge 
associated with phosphorylation. In vzYro-translated TRa mutants or wild type TRa were 
then micro injected into the cytoplasm of Xenopus oocytes and incubated for 3 h at 20°C 
to allow the nucleocytoplasmic distribution o f TRa to reach a steady-state.
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All the mutants showed a similar nucleocytoplasmic distribution when compared 
to the wild type (Fig. 9A). In this set of experiments, 39% (n=18) of wild type TRa 
localized to the nucleus. Similarly, 40% (n=10) of the glutamic acid mutant, 40% (n=14) 
of the alanine mutant, 42% (n=12) of the threonine mutant, and 39% (n=8 ) of the A12 
deletion mutant localized to the nucleus after cytoplasmic injection. Statistical analysis 
confirmed that the distribution patterns of mutant and wild type TRas were not 
significantly different (student’s t-test, P>0.15). It should be noted that the percentage of 
wild type TRa localized to the nucleus is higher than seen in the experiments 
summarized in Fig. 7B. This result could simply be due to the differences seen between 
different batches of oocytes. However, in the experiments shown in Fig. 7, control 
oocytes were incubated in medium containing DMSO and it is possible that DMSO 
slightly inhibits nuclear import in an unknown fashion.
Surprisingly, the alanine, glutamic acid, and A12 deletion mutants, which cannot 
be phosphorylated at position 12, all showed an altered mobility on SDS-polyacrylamide 
gels similar to the altered mobility of wild type TRa previously described (Fig. 6 A). To 
determine if the altered mobility of these mutants was due to phosphorylation, alkaline 
phosphatase assays were performed on the alanine and deletion mutants as well as the 
wild type TRa. Figure 9B shows the results for the wild type and the A12 deletion 
mutant. Alkaline phosphatase treated nuclear samples had the same mobility as untreated 
cytoplasmic samples (compare lanes 1 and 3 and lanes 4 and 6 ). The mock-treated 
nuclear samples maintained their altered shift when compared to the untreated 
cytoplasmic samples or the alkaline phosphatase-treated samples (compare lane 2  with 
lanes 1 and 3, and lane 5 with lanes 4 and 6 ). Likewise, alanine mutant TRa recovered
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Figure 9(A). Phosphorylation of TRa at serine 12 is not 
required for nuclear import or nuclear retention. S-
labeled position 12 mutants were injected into the 
cytoplasm of Xenopus oocytes. The oocytes were incubated 
for 3 h and divided into cytoplasmic (C) and nuclear (N) 
fractions and analyzed as described in Fig. 6. Lanes 1 and 2 
represent wild type TRa (serine at position 12); 3 and 4, 
the glutamic acid mutant; 5 and 6, the alanine mutant; 7 
and 8, the threonine mutant; and 9 and 10, the Al2 deletion 
mutant. (B) TRa has other phosphorylation sites. 
Xenopus oocytes were cytoplasmically micro injected with 
35S-TRa (lanes 1-3) and the A12 deletion mutant (lanes 4- 
6). After 3 h incubation at 20°C, oocytes were manually 
dissected and proteins extracted from 6 cytoplasmic (C) or 
nuclear fractions. Nuclear fractions were treated with 
alkaline phosphatase (A) and incubated for 1 h at 37°C or 
were mock-treated with buffer alone (M). Cytoplasmic 
fractions were left untreated. Proteins were separated by 
12% SDS-PAGE, followed by fluorography.
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from alkaline phosphatase treated nuclear fractions did not show an altered mobility after 
SDS-PAGE; instead the mutants had the same mobility as mutant TRa recovered from 
untreated cytoplasmic samples (data not shown). Thus, the mobility shift demonstrated 
by the mutants appears to be due to phosphorylation, suggesting that there are other 
important, but cryptic phosphorylation sites within TRa.
Discussion
Phosphorylation has been shown to be important in regulating a number of 
cellular and molecular events, including nuclear import and retention of transcription 
factors. In the present study, Xenopus oocyte micro injection assays have shown that 
phosphorylation of a well-characterized casein kinase II site at serine 12 is not necessary 
for the nuclear import and retention of TRa. However, a phosphorylated form of TRa is 
present in the oocyte nucleus and increasing the phosphorylation state of the oocyte 
enhances nuclear retention of TRa. Furthermore, changes in the phosphorylation state of 
TRa occur rapidly and are compartment-specific. Taken together, these data provide 
evidence that, phosphorylation of a site(s) other than serine 1 2  has an important role in 
regulating the nuclear activity of TRa.
Phosphorylation o f serine 12 is not necessary for the nuclear import and retention o f 
TRa
Since TRa is a phosphoprotein, there is the potential that some of its functions are 
regulated by phosphorylation. These functions could include DNA binding, hormone 
binding, transcriptional activation, dimer formation, and nuclear import and retention. 
TRa has recently been shown to be a shuttling protein and, thus, phosphorylation could 
play a role in regulating its intracellular movement (Bunn et al., 2001). Serine 12 is the 
most well-characterized phosphorylation site, making this residue a good candidate for
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mutagenesis (Glineur et al, 1989; Goldberg et al., 1988). Furthermore, this residue is 
conserved in all members of the TR family suggesting an important biological role. 
Results from this research suggest, however, that serine 12 is not necessary for the 
nuclear import and retention of rat TRa. The individual mutants generated in this study 
not only removed the ability of this residue to be phosphorylated (alanine mutant and A12 
deletion mutant), but also mimicked the negative charge found on a phosphorylated 
residue (glutamic acid mutant) (Glineur et al., 1990). All the mutant proteins were 
imported into the nucleus and showed a similar nucleocytoplasmic distribution when 
compared to the wild type. Most strikingly, none of the first twelve amino acids, which 
include another predicted phosphorylation site, a serine at position 6  (Fig. 10), were 
shown to be necessary for nuclear import. The A12 deletion mutant also entered the 
nucleus and showed the same nucleocytoplasmic distribution as full length TR. This 
mutant also showed an altered mobility on denaturing SDS polyacrylamide gels, 
providing further evidence that there are other phosphorylation site(s). These 
observations are in agreement with an earlier report showing that the phosphorylation site 
at position 12 in chicken TRa was not essential for nuclear localization in cultured 
mammalian cells (Andersson and Vennstrom, 1997). Interestingly, chicken TRa has a 
well-characterized protein kinase A phosphorylation site at serines 28 and 29; however, 
this site is not conserved in rat TRa (Jones et al., 1994; Sugawara et al., 1994). This is of 
interest since this site has been shown to be important for the biological activity of the 
oncogenic homo log of TRa v-erbA (Glineur et al., 1989).
The results reported here showing that phosphorylation of serine 12 is not 
necessary for nuclear import of TRa do not rule out the possibility that phosphorylation
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Figure 10. Predicted phosphorylation sites in TRa. Results showing 
putative phosphorylation sites using the NetPhos 2.0 search engine. Threshold 
is the likelihood that a particular site will be phosphorylated. This value is set 
at 50, any site below this number or close to it is not likely to be a 
phosphorylation site, while higher values are more likely to be a true 
phosphorylation site.
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of one or more other sites is necessary for nuclear import. All the mutants retained their 
ability to be phosphorylated, suggesting that there is indeed at least one other 
phosphorylation site that has yet to be characterized. Phosphorylation of these additional 
individual site(s) may be necessary for nuclear import, or these sites may work in consort 
to contribute to the phosphorylation state of TRa, allowing nuclear import. Thus, these 
sites would be able to maintain the necessary phosphorylation state for import, even in 
the event of the loss of one of the other sites.
Phosphorylation has been shown to have a role in the nuclear import of a number 
of proteins including Dorsal, Pho4, and the hepatitis B core particle (Drier et al., 1999; 
Kaffman et al., 1998; Kann et al., 1999). Of particular interest is the regulation of the 
transcription factor Pho4, since it has been shown that its nuclear activity is regulated by 
its phosphorylation state. When Pho4 is unphosphorylated by the actions of a kinase 
inhibitor, transcription occurs; however, when Pho4 is phosphorylated, it is exported to 
the cytoplasm. Furthermore, this transcription factor has multiple phosphorylation sites 
with different functions including import, export, and binding to other transcription 
factors (Komeili and O'Shea, 1999). The phosphorylation of these different sites 
provides tight regulation of the activity of Pho4. These results could provide a model for 
TRa, since it is clear from the results of the present study that there are multiple 
phosphorylation sites present within TRa. The phosphorylation or dephosphorylation of 
these sites could regulate the specific activities of TRa.
TRa has been shown to shuttle rapidly between the nucleus and cytoplasm in 
mammalian cells (Bunn et al., 2001). Phosphorylation could play a role in this shuttling, 
since it has been shown that the glucocorticoid receptor (GR) shuttling is regulated by
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phosphorylation (Dean et al., 2001; DeFranco et al., 1991). In this case, researchers 
reported that protein phosphatase types 1 and 2 A regulated the shuttling of GR.
Inhibiting the phosphatases led to a loss of nuclear retention, which caused GR to remain 
in the cytoplasm (DeFranco et al., 1991). Further evidence for the role of 
phosphorylation in the shuttling of GR is provided by Dean et al. (2001). They report 
that protein phosphatase 5 (PP5) is involved in the regulation of GR shuttling.
Suppression of PP5 results in the nuclear accumulation of phosphorylated GR and leads 
to an increase in transcriptional activity (Dean et al., 2001). The mechanisms suggested 
for GR shuttling may provide a model for TR shuttling.
It is clear that phosphorylation plays a role in the activity of a host of transcription 
factors, thus finding and characterizing the cryptic sites in TRa provides an important 
area of research. These uncharacterized sites may explain some of the conflicting results 
found in the literature regarding the importance of phosphorylation for hormone binding 
and DNA binding, as well as the importance of various phosphorylation sites for other 
activities of TRa. It is certainly possible that differing experimental conditions could 
trigger these cryptic sites in different ways, thus creating the confusion seen in the 
literature. For example, many of the DNA binding studies (see Introduction, ‘TR 
phosphorylation”) used different cell lines, which have varying phosphatase and kinase 
concentrations. It is conceivable that in these different backgrounds some 
phosphorylation sites of TRa would be more active than others, thus yielding different 
results. This possibility is not without precedence; for example, the relative importance of 
phosphorylation of Dorsal in Drosophila (see Introduction, “Phosphorylation o f 
transcription factors and viral proteins”) varies in different backgrounds. In a wild-type
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signaling background there was only a weak loss of function in phosphorylation mutants 
of Dorsal (Drier et a l, 1999). However, when these same mutants were placed in a 
Cactus mutant background the Dorsal phosphorylation mutants were completely 
destabilized. These results demonstrate that the design of the experiment is critical and 
must be considered when analyzing the data.
Phosphorylation enhances nuclear retention o f  TRa
There are many examples in the literature demonstrating the importance of 
phosphorylation in the activity of transcription factors (DeFranco et al., 1991; Komeili 
and O’Shea, 1999; Moroianu, 1999). Of particular interest, several reports have shown 
that phosphorylation of nuclear receptors can alter DNA binding affinity. In some cases, 
DNA binding of ER and PR, as well as TR, has been shown to be enhanced in the 
presence of compounds known to increase phosphorylation (Arnold et al., 1995; Bagchi 
et al., 1992; Bhat et al., 1994; Denton et al., 1992; Lin et al., 1992). However, there are 
other reports which demonstrate that phosphorylation is not necessary for DNA binding. 
Despite these conflicting reports, increased nuclear retention of phosphorylated TRa 
because of enhanced DNA binding remains an intriguing possibility, since it has also 
been shown that phosphorylation of TRa can increase transcriptional activation of T 3 -  
responsive genes (Jones et al., 1994; Ting et al., 1997). Despite serine 12 not being 
necessary for nuclear import of TRa, it is clear from the results of this thesis and 
previous studies that phosphorylation plays a role in the nuclear events of TRa. In 
Xenopus oocytes, TRa is not localized exclusively to the nucleus. This lack of 
localization allowed the manipulation of the phosphorylation state of the oocytes and in
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turn changed the localization pattern of TRa. Increasing the overall phosphorylation state 
of Xenopus oocytes by treatment with IBMX, a known inhibitor of phosphodiesterase and 
a protein kinase A activator, led to a significant increase in the nuclear localization of 
TRa. This result is consistent with studies mentioned above which showed that 
phosphorylation can enhance DNA binding in vitro and increase dimerization with RXR, 
both of which would promote nuclear localization (Bhat et al., 1994; Tzagarakis-Foster 
and Privalsky, 1998). Further evidence that phosphorylation enhances nuclear 
localization of TRa is provided by the current finding that phosphorylated TRa injected 
into the nucleus of Xenopus oocytes remains predominantly nuclear even after 3 hours. 
Taken together, these results lead to several interesting questions. Does the 
phosphorylated form of TRa bind DNA with greater affinity in vivo, thus promoting 
nuclear retention? Does phosphorylation increase the rate of nuclear import or slow 
down the rate of nuclear export of TRa?
Phosphorylation, by enhancing DNA binding could allow more TRa to remain in 
the nucleus, which would in turn lead to an increase in transcription in the presence of T3 , 
and to an increase in gene repression in the absence of T3 . Mammalian cells show a 
different distribution of TRa compared with Xenopus oocytes, as TRa is primarily 
nuclear but individual receptors undergo rapid nucleocytoplasmic shuttling (Bunn et al., 
2001). As discussed earlier, GR also undergoes shuttling and this shuttling is regulated 
by phosphorylation/dephosphorylation signals (Dean et al., 2001; DeFranco et al., 1991). 
A similar model could be applied to TRa shuttling in mammalian cells, in which 
phosphorylation could effect the rate of import or export. Nuclear TRa could be largely 
phosphorylated. However, at any given time, an individual receptor could be
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dephosphorylated and exported, and then quickly reimported. Nuclear retention of TRa 
could thus be the result of the export machinery being unable to bind a phosphorylated 
receptor. There is evidence that phosphorylation/dephosphorylation can directly alter the 
binding affinity of a protein for its import/export machinery. One example is in yeast 
where Gln3p, a transcription factor for the nitrogen catabolite repressible gene, has its 
nucleocytoplasmic distribution determined by its phosphorylation state. When 
phosphorylated this protein is unable to bind to its import receptor and thus remains 
cytoplasmic (Carvalho et al., 2001). This inability to bind TR could also be the result of 
the phosphorylated receptor’s increased association with DNA, as previously discussed, 
or of the receptor binding to the nuclear matrix. The nuclear matrix is an insoluble array 
of filaments which provides the structure and compartmentalization of the nucleus 
(DeFranco, 1997). There is evidence that unliganded GR can either bind to the nuclear 
matrix after release from chromatin or undergo nuclear export (DeFranco, 1997; Yang et 
al., 1997). TR has also been shown to associate with the nuclear matrix (C. Bunn, N. 
Hollingshead, P. Garcia, L. Allison, unpublished results). Thus, a model could be 
proposed in which this binding would prevent access to the export machinery and slow 
down the rate of export. Clearly, more work needs to be done in both mammalian cells 
and Xenopus oocytes to test this model and complete our understanding.
Changes in phosphorylation state occur rapidly in Xenopus oocytes
To be effective as a molecular and signaling mechanism, a signal must be rapid. 
This present study demonstrates that dephosphorylation/phosphorylation of TRa in
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Xenopus oocytes occurs, within minutes or less. These results are in agreement with work 
done with PHAX, a nuclear export protein (Ohno et al, 2000). In this study, PHAX was 
in vitro translated in rabbit reticulocyte lysate and microinjected into either the nucleus 
and cytoplasm o f Xenopus oocytes. The authors report that PHAX is subject to rapid 
dephosphorylation in the cytoplasm, while PHAX injected into the nucleus remains 
phosphorylated (Ohno et al., 2000). Furthermore, unphosphorylated PHAX, when 
injected into the nucleus underwent phosphorylation (Ohno et al., 2000). A similar 
distribution is reported here: TRa injected into the nucleus remained primarily nuclear 
after 3 h and showed the slower mobility on SDS-PAGE associated with 
phosphorylation, while TRa found in the cytoplasm was unphosphorylated and had a 
slower mobility. Furthermore, TRa injected into the cytoplasm remained primarily in the 
cytoplasm after immediate dissection and showed the same mobility as cytoplasmic 
fractions after 3 h demonstrating the dephosphorylated form of TRa.
Ohno et al. (2000) showed that rabbit reticulocyte lysate has kinase activity and is 
capable of phosphorylating PHAX. Interestingly the authors also demonstrated that 
PHAX can be phosphorylated by casein kinase II in vitro. This activity was confirmed 
by adding rabbit reticulocyte lysate to PHAX translated in bacteria, which is 
unphosphorylated. In the presence of the lysate PHAX was phosphorylated and showed 
an altered mobility on SDS-PAGE. This kinase activity is of particular interest since it 
has been shown that TRa can also be phosphorylated by casein kinase II at serine 12 and 
several of the putative sites, specifically serine 45 and serine 203, show casein kinase II 
consensus sites (Fig. 10). Unfortunately, a bacterial expression vector, that would generate 
an unphosphorylated TRa, since eukaryotic proteins do not undergo post-translational
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modification in bacteria, is not currently available. Thus, direct confirmation of 
phosphorylation occurring in the nucleus cannot be performed yet. However, taken 
together the results presented here suggest that, similarly to PHAX, phosphorylation 
occurs rapidly and probably occurs in the nucleus. More experiments will need to be 
performed in order to demonstrate that phosphorylation occurs in the nucleus of Xenopus 
oocytes. If this is indeed the case, this would suggest that phosphorylation of TRa does 
not directly effect nuclear import but, instead, enhances nuclear retention and inhibits 
export.
Future directions
Research on TR function and its regulation has expanded greatly over the last 
decade; however, more research is needed. First, as Fig. 10 shows, there are a number of 
potential phosphorylation sites. One or several of these sites could be important in the 
cellular and molecular events described in this study, such as nuclear retention and 
nuclear import and export. Clearly, more work needs to be done to confirm the presence 
of these sites, including carrying out site-directed mutagenesis to learn how these regions 
effect receptor behavior. In addition, more research needs to be done on manipulating the 
phosphorylation state of the cell system being studied. There are a host of inhibitors and 
activators of kinases and phosphatases available that could be used, including protein 
phosphatase 1 and 2A, PKA, H7, or forskolin, as well as phosphate depletion assays. 
Antibodies against specific kinases found in the cell system being used could provide a 
great deal of information. To complete the story of phosphorylation, this work needs to 
be complemented with mammalian cell line studies, including phosphate depletion
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assays, and nucleocytoplasmic shuttling assays in heterokaryons, as well as in vitro 
nuclear import assays. These assays will help complete the picture and allow for the 
development of a model for nuclear retention and localization. Finally, the development 
of a bacterial expression vector for TRa would greatly enhance the study of 
phosphorylation. The ability to purify mg quantities of protein would make it easier to 
study the localization and movement of this receptor. A greater quantity of protein would 
make it possible to phosphorylate TRa in vitro, and, as mentioned earlier, TRa generated 
from bacteria would not be phosphorylated and thus could be used to provide direct 
evidence for the role of phosphorylation in nuclear retention and for the specific sites of 
phosphorylation.
Conclusion
With regard to TRa the role of phosphorylation in cellular and molecular events 
remains enigmatic. Results presented here show that phosphorylation increases nuclear 
retention of TRa in Xenopus oocytes. The mechanism remains unclear, however, and 
this uncertainty generates exciting new directions for research. Furthermore, this 
research shows that the first 12 amino acids are not necessary for nuclear import. 
Similarly, the phosphorylation state of serine 12 is not necessary for either nuclear import 
or retention. However, given that nuclear TRa is phosphorylated, it remains to be 
determined whether the phosphorylation state of TRa is directly involved in its nuclear 
import or whether phosphorylation occurs in the nucleus and plays a direct role in 
promoting nuclear retention.
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Phosphorylation plays a major role in human health. Over 700 protein kinases and 
phosphatases are encoded by the human genome (Cohen, 2001). A host of human 
diseases are the result of mutations or malfunctions in the phosphorylation machinery, 
including some forms of leukemia, Non-Hodgkins lymphoma, and diabetes (Cohen, 
2001). Furthermore, many pathogens produce virulence factors that target the 
phosphorylation machinery, most notably the bacteria Yersinia which causes bubonic 
plague (Cohen, 2001). Malfunctions in TR function such as mutations in TR(3 lead to the 
disease resistance to thyroid hormone. The resulting disease has various symptoms 
including goiter and slow development. Thus, understanding the mechanisms regulated 
by phosphorylation, and the proteins which carry out these functions, is of great 
importance.
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